{"mainPropery":{"diseaseId":7401,"diseaseName":"Pityriasis rubra pilaris","hasGardWebPage":true,"isRare":true,"websiteUrl":"https://rarediseases.info.nih.gov/diseases/7401/pityriasis-rubra-pilaris","synonyms":[],"synonyms-with-source":[],"identifiers":[{"identifierType":"OMIM","identifierId":"173200"},{"identifierType":"ORPHANET","identifierId":"2897"}]},"diseaseCategories":[{"diseaseTypeId":5,"diseaseTypeName":"Congenital and Genetic Diseases","source":"Orphanet"},{"diseaseTypeId":22,"diseaseTypeName":"Skin Diseases","source":"Orphanet"}],"organizations":[{"resourceID":376,"resourceName":"Foundation for Ichthyosis and Related Skin Types","abbreviation":"FIRST","address1":"2616 North Broad Street","address2":"","address3":"","address4":"","address5":"","city":"Colmar","state":"PA","zip":"18915 ","country":"United States","phone":"+1-215-997-9400","tty":"","tollFree":"1-800-545-3286","fax":"","email":"info@firstskinfoundation.org","url":"http://www.firstskinfoundation.org/","freeText":""},{"resourceID":3653,"resourceName":"PRP Alliance","abbreviation":"","address1":"1500 Commerce Drive","address2":"","address3":"","address4":"","address5":"","city":"Plano","state":"TX","zip":"75093-2640","country":"","phone":"214-205-0574","tty":"","tollFree":"","fax":"","email":"","url":"http://prpalliance.org","freeText":""}],"resource descriptions":[{"id":7,"resourceId":10,"resourceName":"Online Mendelian Inheritance in Man (OMIM)","descriptionText":"<a href='http://www.omim.org/173200' target='_blank'>Online Mendelian Inheritance in Man (OMIM)</a> is a catalog of human genes and genetic disorders. Each entry has a summary of related medical articles. It is meant for health care professionals and researchers. OMIM is maintained by Johns Hopkins University School of Medicine.&nbsp;<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":8,"resourceId":11,"resourceName":"PubMed","descriptionText":"<a href='https://www.ncbi.nlm.nih.gov/pubmed/?term=pityriasis+rubra+pilaris' target='_blank'>PubMed</a> is a searchable database of medical literature and lists journal articles that discuss Pityriasis rubra pilaris. Click on the link to view a sample search on this topic.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":10,"resourceId":13,"resourceName":"MedlinePlus Genetics","descriptionText":"<a href='http://ghr.nlm.nih.gov/condition/familial-pityriasis-rubra-pilaris' target='_blank'>Genetics Home Reference (GHR)</a> contains information on Pityriasis rubra pilaris. This website is maintained by the National Library of Medicine.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1457,"resourceId":2104,"resourceName":"Genetic Services","descriptionText":"To find a medical professional who specializes in genetics, you can ask your doctor for a referral or you can search for one yourself. Online directories are provided by the <a href='http://www.acmg.net/ACMG/Genetic_Services_Directory_Search.aspx' target='_blank'>American College of Medical Genetics</a> and the&nbsp;<a href='https://www.findageneticcounselor.com/' target='_blank'>National Society of Genetic Counselors</a>. If you need additional help, <a href=\"https://rarediseases.info.nih.gov/about-gard/contact-gard\">contact a GARD Information Specialist</a>. You can also&nbsp;<a href='https://ghr.nlm.nih.gov/primer#consult' target='_blank'>learn more about genetic consultations</a>&nbsp;from Genetics Home Reference.","resourceClassificationName":"Find a Specialist","resourceClassificationSectionName":"Healthcare Resources"},{"id":1526,"resourceId":2158,"resourceName":"Genetic Testing Registry","descriptionText":"The <a href='https://www.ncbi.nlm.nih.gov/gtr/conditions/C0032027/' target='_blank'>Genetic Testing Registry</a> (GTR) provides information about the genetic tests for this condition. The intended audience for the GTR is health care providers and researchers. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.<br />\r\n","resourceClassificationName":"Diagnosis","resourceClassificationSectionName":"Testing Resources"},{"id":1527,"resourceId":2159,"resourceName":"National Organization for Rare Disorders","descriptionText":"The <a href='https://rarediseases.org/rare-diseases/pityriasis-rubra-pilaris/' target='_blank'>National Organization for Rare Disorders</a> (NORD) has a report for patients and families about this condition. NORD is a patient advocacy organization for individuals with rare diseases and the organizations that serve them.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1531,"resourceId":2162,"resourceName":"Medscape Reference","descriptionText":"<a href='http://emedicine.medscape.com/article/1107742-overview' target='_blank'>Medscape Reference</a> provides information on this topic. You may need to register to view the medical textbook, but registration is free.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1534,"resourceId":2165,"resourceName":"Orphanet","descriptionText":"<a href='http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=2897' target='_blank'>Orphanet</a> is a European reference portal for&nbsp;information on rare diseases and orphan drugs. Access to this database is free of charge.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1545,"resourceId":2173,"resourceName":"Merck Manual","descriptionText":"The <a href='http://www.merckmanuals.com/home/skin-disorders/psoriasis-and-scaling-disorders/pityriasis-rubra-pilaris' target='_blank'>Merck Manuals Online Medical Library</a> provides information on this condition for patients and caregivers.&nbsp;","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1550,"resourceId":2178,"resourceName":"DermNet New Zealand","descriptionText":"<a href='http://www.dermnetnz.org/scaly/pityriasis-rubra-pilaris.html' target='_blank'>DermNet New Zealand</a> is an online resource about skin diseases developed by the New Zealand Dermatological Society Incorporated. DermNet NZ provides information about this condition.","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1591,"resourceId":2206,"resourceName":"Facebook Groups","descriptionText":"Visit the <a href='https://www.facebook.com/groups/15865278115/' target='_blank'>Pityriasis Rubra Pilaris (PRP)</a> group on Facebook.","resourceClassificationName":"Organizations","resourceClassificationSectionName":"Social Networking Websites"},{"id":1700,"resourceId":2173,"resourceName":"Merck Manual","descriptionText":"The&nbsp;<a href='http://www.merckmanuals.com/professional/dermatologic-disorders/psoriasis-and-scaling-diseases/pityriasis-rubra-pilaris' target='_blank'>Merck Manual</a> for health care professionals provides information on&nbsp;Pityriasis rubra pilaris.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":2135,"resourceId":3342,"resourceName":"Monarch Initiative","descriptionText":"The <a href='https://monarchinitiative.org/disease/OMIM:173200' target='_blank'>Monarch Initiative</a> brings together data about this condition from humans and other species to help physicians and biomedical researchers. Monarch&rsquo;s tools are designed to make it easier to compare the signs and symptoms (phenotypes) of different diseases and discover common features. This initiative is a collaboration between several academic institutions across the world and is funded by the National Institutes of Health. Visit the website to explore the biology of this condition.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":2311,"resourceId":3517,"resourceName":"RareConnect","descriptionText":"<a href='https://www.rareconnect.org/en/community/pityriasis-rubra-pilaris' target='_blank'>RareConnect</a>, an online community partnered with EURORDIS, an international patient organization, has a&nbsp;Pityriasis rubra pilaris community","resourceClassificationName":"Organizations","resourceClassificationSectionName":"Social Networking Websites"},{"id":2458,"resourceId":3653,"resourceName":"PRP Alliance","descriptionText":"The&nbsp;<a href='http://prpalliance.com/survival-guide/' target='_blank'>PRP Alliance</a> includes information on current research for pityriasis rubra pilaris within the PRP Survival Guide.","resourceClassificationName":"Research","resourceClassificationSectionName":"Clinical Research Resources"}],"overviewQuestion":{"questionId":3642,"questionText":"What is pityriasis rubra pilaris?","answerText":"<strong>Pityriasis rubra pilaris</strong> (PRP) refers to a group of skin conditions that cause constant inflammation and scaling of the skin.[2545] People with PRP have reddish, scaly patches that may occur everywhere on the body, or only on certain areas.[7255][14002] Some people with PRP also develop thickened skin on the underside of the hands and feet (<a href=\"https://rarediseases.info.nih.gov/diseases/8167/palmoplantar-keratoderma\" target=\"_blank\">palmoplantar keratoderma</a>), various nail abnormalities, and/or thinning of the hair.[14003] There are several types of PRP classified by age when symptoms begin, body areas involved, and whether other conditions are present.[7255][2546] This condition occurs in adults (adult onset PRP) as well as children (juvenile onset PRP).[14003]<br />\r\n<br />\r\nIn most cases, PRP is not inherited and the cause is not known. In some people, particularly some with type V (the &ldquo;atypical juvenile type&rdquo;), PRP has autosomal dominant inheritance and may be caused by mutations in the <em><a href=\"https://ghr.nlm.nih.gov/gene/CARD14\" target=\"_blank\">CARD14</a></em> gene.[14004][14005]<br />\r\n<br />\r\nTreatment options vary based on symptoms and severity. No one treatment works for all people with PRP. Examples of treatment options include topical <a href=\"https://www.dermnetnz.org/topics/emollients-and-moisturisers/\" target=\"_blank\">emollients</a> or medications, oral <a href=\"https://www.dermnetnz.org/topics/oral-retinoids/\" target=\"_blank\">retinoids</a>, and/or <a href=\"https://www.dermnetnz.org/topics/immunosuppressive-drugs/\" target=\"_blank\">immunosuppressants</a>.[7255][14003][2546]","dateModified":"2017-10-30T00:00:00"},"basicQuestions":[{"questionId":3644,"questionText":"What are the signs and symptoms of pityriasis rubra pilaris?","answerText":"Features of this condition vary greatly from person to person. Signs and symptoms often get worse over time and may affect the skin, nails, <a href=\"https://medlineplus.gov/ency/article/002264.htm\" target=\"_blank\">mucous membranes</a>, and eyes.[7255] Signs and symptoms may include:<br />\r\n<ul>\r\n    <li>Redness and scaling of the skin and scalp, which often develops into itchy, orange-red plaques. Plaques may first occur on only some parts of the body, but may eventually spread over the whole body.[14003] The elbows, knees, ankles, hands and feet are most commonly affected.[7255]</li>\r\n    <li>Thickening of the skin on the palms and soles (<a href=\"https://rarediseases.info.nih.gov/diseases/8167/palmoplantar-keratoderma\" target=\"_blank\">palmoplantar keratoderma</a>).[2546]</li>\r\n    <li>Thickening, discoloration, or shedding of the nails.[2546]</li>\r\n    <li>Thinning of the hair.[14003]</li>\r\n    <li>Plaques and irritation in the mouth.[2546]</li>\r\n    <li>Dryness of the eyes and/or <a href=\"https://www.mayoclinic.org/diseases-conditions/ectropion/symptoms-causes/syc-20351164\" target=\"_blank\">ectropion</a> (outward turning of the eyelid).[2546]</li>\r\n    <li>Reduced quality of life associated with persistent pain, itching, or sleep disturbances.[14002]</li>\r\n</ul>\r\nInformation about the <a href=\"https://www.dermnetnz.org/topics/pityriasis-rubra-pilaris/\" target=\"_blank\">types of PRP</a> and how they differ is available from DermNet New Zealand.","dateModified":"2017-10-30T00:00:00","resourceClassificationName":"Symptoms","references":[{"referenceId":2546,"authors":"Shenefelt PD","articleTitle":"Pityriasis Rubra Pilaris","bookWebsiteJournalTitle":"Medscape Reference","date":"April 17, 2017","volume":"","pages":"","url":"http://emedicine.medscape.com/article/1107742-overview","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":7255,"authors":"Oakley A","articleTitle":"Pityriasis rubra pilaris","bookWebsiteJournalTitle":"DermNet New Zealand","date":"October, 2015","volume":"","pages":"","url":"https://www.dermnetnz.org/topics/pityriasis-rubra-pilaris/","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":14002,"authors":"","articleTitle":"Pityriasis Rubra Pilaris","bookWebsiteJournalTitle":"National Organization for Rare Disorders (NORD)","date":"2017","volume":"","pages":"","url":"https://rarediseases.org/rare-diseases/pityriasis-rubra-pilaris","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":14003,"authors":"Katsambas A and Dessinioti C","articleTitle":"Pityriasis rubra pilaris","bookWebsiteJournalTitle":"UpToDate","date":"March 10, 2017","volume":"","pages":"","url":"https://www.uptodate.com/contents/pityriasis-rubra-pilaris","authors2":"","placeOfPublication":"Waltham, MA","publisher":"UpToDate"}]},{"questionId":3643,"questionText":"What causes pityriasis rubra pilaris?","answerText":"In the vast majority of people with PRP, the cause is unknown.[7255] Most cases are thought to result from a combination of unknown genetic factors and environmental triggers.[14002]<br />\r\n<br />\r\nRarely, PRP&nbsp; is due to changes (mutations) in a gene called <em><a href=\"http://ghr.nlm.nih.gov/gene/CARD14\" target=\"_blank\">CARD14</a></em>.[7259][14006][14004] Mutations in this gene are found particularly in people with PRP type V. This gene gives the body instructions for making a protein involved in regulating the body's immune responses and inflammatory reactions. While the protein is present in many of the body&rsquo;s tissues, it is found in great amounts in the skin. Mutations in this gene are thought to trigger an abnormal inflammatory response, leading to the signs and symptoms of PRP.[7259]","dateModified":"2017-10-30T00:00:00","resourceClassificationName":"Cause","references":[{"referenceId":7255,"authors":"Oakley A","articleTitle":"Pityriasis rubra pilaris","bookWebsiteJournalTitle":"DermNet New Zealand","date":"October, 2015","volume":"","pages":"","url":"https://www.dermnetnz.org/topics/pityriasis-rubra-pilaris/","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":7259,"authors":"","articleTitle":"Familial Pityriasis Rubra Pilaris","bookWebsiteJournalTitle":"Genetics Home Reference","date":"March, 2013","volume":"","pages":"","url":"http://ghr.nlm.nih.gov/condition/familial-pityriasis-rubra-pilaris","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":14002,"authors":"","articleTitle":"Pityriasis Rubra Pilaris","bookWebsiteJournalTitle":"National Organization for Rare Disorders (NORD)","date":"2017","volume":"","pages":"","url":"https://rarediseases.org/rare-diseases/pityriasis-rubra-pilaris","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":14004,"authors":"Takeichi T, Sugiura K, Nomura T, et al.","articleTitle":"Pityriasis Rubra Pilaris Type V as an Autoinflammatory Disease by CARD14 Mutations","bookWebsiteJournalTitle":"JAMA Dermatol","date":"January 1, 2017","volume":"153(1)","pages":"66-70","url":"https://www.ncbi.nlm.nih.gov/pubmed/27760266","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":14006,"authors":"O'Neill MJF","articleTitle":"Pityriasis Rubra Pilaris; PRP","bookWebsiteJournalTitle":"Online Mendelian Inheritance in Man (OMIM)","date":"July 31, 2012","volume":"","pages":"","url":"https://www.omim.org/entry/173200","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":3645,"questionText":"How might pityriasis rubra pilaris be treated?","answerText":"PRP can be difficult to treat and many treatment options have been tried. There is little information on which treatments are best because none have been studied in large clinical trials. Treatment options may vary based on the symptoms in each person but often involve a combination of medicines taken internally and applied topically to the skin.[7255]<br />\r\n<br />\r\nTopical therapy options may include <a href=\"http://dermnetnz.org/treatments/topical-steroids.html\" target=\"_blank\">corticosteroids</a>, keratolytics, <a href=\"http://www.dermnetnz.org/treatments/calcipotriol.html\" target=\"_blank\">calcipotriol</a>, <a href=\"http://www.nlm.nih.gov/medlineplus/druginfo/meds/a682437.html\" target=\"_blank\">tretinoin</a>, and <a href=\"http://www.mayoclinic.org/drugs-supplements/tazarotene-topical-route/description/drg-20067364\" target=\"_blank\">tazarotene</a>. For people with mild PRP, using one or more of these may be enough to control symptoms.[14003]<br />\r\n&nbsp;<br />\r\nMost people with PRP also need additional medicines to control their symptoms, especially if the condition affects a large part of the body.[14003] <a href=\"http://dermnetnz.org/treatments/oral-retinoids.html\" target=\"_blank\">Oral retinoids</a> are usually tried first.[14003] Examples include <a href=\"https://medlineplus.gov/druginfo/meds/a601010.html\" target=\"_blank\">acitretin</a> and <a href=\"https://medlineplus.gov/druginfo/meds/a681043.html\" target=\"_blank\">isotretinoin</a>.[2546] <a href=\"https://medlineplus.gov/druginfo/meds/a682019.html\" target=\"_blank\">Methotrexate</a>, an immune system suppressant, may be tried when oral retinoids are not safe for a particular person, or when they have stopped working.[14003] Other immune system suppressants that have been helpful in some case reports include <a href=\"https://medlineplus.gov/druginfo/meds/a601207.html\" target=\"_blank\">cyclosporine</a> and <a href=\"https://medlineplus.gov/druginfo/meds/a682167.html\" target=\"_blank\">azathioprine</a>.[14003][2546] <a href=\"https://www.fda.gov/aboutfda/centersoffices/officeofmedicalproductsandtobacco/cber/ucm133077.htm\" target=\"_blank\">Biologic therapies</a> may be another option, based on limited data. Examples include various <a href=\"http://www.fda.gov/Drugs/drugsafety/postmarketdrugsafetyinformationforpatientsandproviders/ucm109340.htm\" target=\"_blank\">biologic TNF-alpha inhibitors</a> and <a href=\"https://medlineplus.gov/druginfo/meds/a611013.html\" target=\"_blank\">ustekinumab</a>.[2546]<br />\r\n<br />\r\nFor more detailed information about treatment options for PRP, you can view information from <a href=\"https://reference.medscape.com/article/1107742-medication#showall\" target=\"_blank\">Medscape Reference</a> or the <a href=\"https://rarediseases.org/rare-diseases/pityriasis-rubra-pilaris/#standard-therapies\" target=\"_blank\">National Organization for Rare Disorders</a> (NORD).<br />\r\n<br />\r\nMany of these treatments have shown results in only a few patients, and some can have serious side effects. The risks and benefits of each treatment option should be discussed with your doctor.","dateModified":"2017-10-30T00:00:00","resourceClassificationName":"Treatment","references":[{"referenceId":2546,"authors":"Shenefelt PD","articleTitle":"Pityriasis Rubra Pilaris","bookWebsiteJournalTitle":"Medscape Reference","date":"April 17, 2017","volume":"","pages":"","url":"http://emedicine.medscape.com/article/1107742-overview","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":7255,"authors":"Oakley A","articleTitle":"Pityriasis rubra pilaris","bookWebsiteJournalTitle":"DermNet New Zealand","date":"October, 2015","volume":"","pages":"","url":"https://www.dermnetnz.org/topics/pityriasis-rubra-pilaris/","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":14003,"authors":"Katsambas A and Dessinioti C","articleTitle":"Pityriasis rubra pilaris","bookWebsiteJournalTitle":"UpToDate","date":"March 10, 2017","volume":"","pages":"","url":"https://www.uptodate.com/contents/pityriasis-rubra-pilaris","authors2":"","placeOfPublication":"Waltham, MA","publisher":"UpToDate"}]},{"questionId":12334,"questionText":"What is the long term outlook for people with pityriasis rubra pilaris?","answerText":"The severity and course of the condition varies depending on the type of PRP a person has.[14003] PRP may go away on its own, have periods of remission (when symptoms improve or go away), improve over time, or it may be chronic (long-lasting).[7255][2546] In some cases, the condition goes away and then returns (relapses) after therapy is stopped.[14003] The following is a general overview of what to expect with each type:[14003][7255]<br />\r\n<ul>\r\n    <li>Type I (classic adult type), the most common type, goes away on its own within 3 years in about 80% of people.&nbsp;After it goes away, relapses are uncommon.</li>\r\n    <li>Type II (atypical adult type) can last for a very long time, sometimes more than 20 years.</li>\r\n    <li>Type III (classic juvenile type) usually goes away within one year. Rarely, this type persists for a longer period of time.</li>\r\n    <li>Type IV (circumscribed juvenile) may be associated with alternating periods of getting better and worse. About one-third of people with this type have improvement with age.</li>\r\n    <li>Type V (atypical juvenile type) is usually chronic.</li>\r\n    <li>Type VI (HIV-associated) tends to be resistant to most treatments.</li>\r\n</ul>\r\nPRP can significantly affect quality of life, especially if there is ongoing pain, itching, or sleep problems.[14002] People with PRP have a normal life expectancy.<br />","dateModified":"2017-10-30T12:04:00","resourceClassificationName":"Prognosis","references":[{"referenceId":2546,"authors":"Shenefelt PD","articleTitle":"Pityriasis Rubra Pilaris","bookWebsiteJournalTitle":"Medscape Reference","date":"April 17, 2017","volume":"","pages":"","url":"http://emedicine.medscape.com/article/1107742-overview","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":7255,"authors":"Oakley A","articleTitle":"Pityriasis rubra pilaris","bookWebsiteJournalTitle":"DermNet New Zealand","date":"October, 2015","volume":"","pages":"","url":"https://www.dermnetnz.org/topics/pityriasis-rubra-pilaris/","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":14002,"authors":"","articleTitle":"Pityriasis Rubra Pilaris","bookWebsiteJournalTitle":"National Organization for Rare Disorders (NORD)","date":"2017","volume":"","pages":"","url":"https://rarediseases.org/rare-diseases/pityriasis-rubra-pilaris","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":14003,"authors":"Katsambas A and Dessinioti C","articleTitle":"Pityriasis rubra pilaris","bookWebsiteJournalTitle":"UpToDate","date":"March 10, 2017","volume":"","pages":"","url":"https://www.uptodate.com/contents/pityriasis-rubra-pilaris","authors2":"","placeOfPublication":"Waltham, MA","publisher":"UpToDate"}]}],"references":[],"relatedDiseases":[],"gardCases":[],"news":[{"newsId":671,"dateCreated":"2020-05-20T13:39:00","publishDate":"2020-05-22T00:00:00","title":"NIH-Supported Research Survey to Examine Impact of COVID-19 on Rare Diseases Community","description":"The NIH-funded Rare Diseases Clinical Research Network (RDCRN) has launched an <a href=\"https://www.rarediseasesnetwork.org/COVIDsurvey \" target=\"_blank\">online research survey</a> to find out how the COVID-19 pandemic is impacting individuals with rare diseases, their families and their caregivers. Your participation can help the rare disease research community shed light on the needs of people with rare diseases during this and other potential health crises, in addition to informing future research efforts. The survey must be completed by December 15, 2020.","url":"https://www.rarediseasesnetwork.org/COVIDsurvey","lastModified":"2020-11-30T14:44:00","isFeatured":false}],"conferences":[],"phenoTypes":[{"phenoTypeId":8301,"phenoTypeName":"Erythroderma","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":5161,"phenoTypeName":"Irregular hyperpigmentation","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":8267,"phenoTypeName":"Palmoplantar keratoderma","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":957,"phenoTypeName":"Papule","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":8271,"phenoTypeName":"Pruritus","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":13337,"phenoTypeName":"Subungual hyperkeratosis","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":9763,"phenoTypeName":"Abnormal oral cavity morphology","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":10132,"phenoTypeName":"Ectropion","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":10289,"phenoTypeName":"Eczema","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":14464,"phenoTypeName":"Ichthyosis","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":11809,"phenoTypeName":"Lichenification","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":13290,"phenoTypeName":"Neoplasm","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":961,"phenoTypeName":"Pustule","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":6539,"phenoTypeName":"Autosomal dominant inheritance","percentRanges":"-"},{"phenoTypeId":12072,"phenoTypeName":"Erythematous plaque","percentRanges":"-"},{"phenoTypeId":5347,"phenoTypeName":"Hypergranulosis","percentRanges":"-"},{"phenoTypeId":6245,"phenoTypeName":"Infantile onset","percentRanges":"-"},{"phenoTypeId":3323,"phenoTypeName":"Keratosis pilaris","percentRanges":"-"},{"phenoTypeId":11508,"phenoTypeName":"Orthokeratosis","percentRanges":"-"},{"phenoTypeId":8314,"phenoTypeName":"Parakeratosis","percentRanges":"-"}],"medicalProducts":[],"EncodedName":"Pityriasis_rubra_pilaris"}